Background Papillary microcarcinoma (PMC) of the thyroid generally follows a benign
clinical course. However, treatment strategies remain controversial. According to our …

Context: Although response to therapy assessment is a validated tool for dynamic risk
stratification in patients with differentiated thyroid cancer (DTC) treated with total …

Context: The surgical management of papillary thyroid microcarcinoma (PTMC), especially
regarding the necessity of central lymph node dissection, remains controversial. Objective …

In many parts of the world, incidence of papillary thyroid cancer is increasing faster than any
other malignancy. Most papillary thyroid cancers that are diagnosed are small and are …

A thyroid incidentaloma is an unexpected, asymptomatic thyroid tumor fortuitously
discovered during the investigation of an unrelated condition. The prevalence rate is 67 …

Background: The treatment for patients with papillary thyroid microcarcinoma (PTMC) is
controversial because PTMC is often found incidentally and its prognosis is very good …

Background: Radioiodine remnant ablation (RRA) has traditionally been one of the
cornerstones of differentiated thyroid cancer (DTC) treatment. The decision to use RRA in …

Background Controversy exists regarding the aggressiveness of initial therapy in childhood
papillary thyroid cancer (PTC). Few studies with long-term outcome exist and second …

Background Two large randomised trials of patients with well-differentiated thyroid cancer
reported in 2012 (HiLo and ESTIMABL1) found similar post-ablation success rates at 6–9 …

BACKGROUND: In clinically node-negative papillary thyroid microcarcinoma (PTMC), the
frequency of subclinical lymph node metastasis (LNM) in the central cervical compartment …